Monoclonal Gammopathy (MG) Associated with Gaucher Disease (GD). Report of 16 Cases from the French Observatoire on Gaucher Disease (FROG Study).

Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 5004-5004
Author(s):  
Bernard Grosbois ◽  
Jean Leone ◽  
Fabrice Camou ◽  
Florence Dalbies ◽  
Jean Robert Harle ◽  
...  

Abstract In addition to its common bone and visceral manifestations GD is frequently associated with B cell proliferation leading possibly to MG. The objective of our study was to determine the frequency and presentation of MG in GD patients. Material and methods. FROG is a cross-sectionnal epidemiological study on adult GD involving 64 French centers. Standard clinical, biological(including serum protein electrophoresis) and imaging data performed as part of usual management within the 3 previous years were collected at the time of a routine visit. In patients with suspected MG specific additionnal data were studied:immunofixation, dosage of immunoglobulins, bone marrow aspiration. Results. From 05/2005 to 06/2006 seventy seven adult GD type 1(38 male,39 female;mean age 47.3 years, range 18 to 78 years) were included. Sixteen cases of MG(20.8%) were observed (10 male and 6 female;mean age 61.25 years, range 47 to 79 years). Mean age of 61 cases of GD without MG(43.8 years;range 18 to 70 years)was significantly lower(p<0.0001). Thirteen cases(17%)were classified as MGUS and 3 (3.8%) as B cell malignancy:1 multiple myeloma, 1 Chronic Lymphocytic Leukemia, 1 Non Hodgkin Lymphoma. In 3 cases MG and GD were diagnosed simultaneously. In 13 cases MG was diagnosed in the course of GD(mean interval 12.2 years;range 6.7 to 16 years). MG immunochemical typing revealed 75 % Ig G, 12.5 %Ig A, 12.5 %Ig M, 75 % Kappa and 25 % Lambda. We observed one biclonal gammopathy(IgG and IgA Kappa). One case of MGUS was associated with capillary leak syndrome. In two patients MG level decreased with enzyme replacement therapy. Conclusion. Frequency of MG in GD observed in our study (20.8%)is largely higher than in general population (1%). Furthermore this frequency is higher than in previous series of GD. However in GD patients, as observed in general population, frequency of MG seems to be related to age as mean age of patients with MG is significantly higher than mean age of patients without MG. Finally these data assess the need of specific follow-up regarding the high frequency of MG and the risk of B cell malignancy in GD patients.

Cancers ◽  
2020 ◽  
Vol 12 (11) ◽  
pp. 3259
Author(s):  
Luca Laurenti ◽  
Dimitar G. Efremov

Chronic lymphocytic leukemia (CLL) is a common B cell malignancy and is the most common type of adult leukemia in western countries [...]


2021 ◽  
Vol 12 ◽  
Author(s):  
Lisa Rohrbacher ◽  
Bettina Brauchle ◽  
Ana Ogrinc Wagner ◽  
Michael von Bergwelt-Baildon ◽  
Veit L. Bücklein ◽  
...  

B-cell receptors, multiple receptor tyrosine kinases, and downstream effectors are constitutively active in chronic lymphocytic leukemia (CLL) B cells. Activation of these pathways results in resistance to apoptosis and enhanced survival of the leukemic cells. Idelalisib is a highly selective inhibitor of the PI3K p110∂ isoform and is approved for the treatment of CLL in patients with relapsed/refractory disease or in those harboring 17p deletions or tp53 mutations. Despite the initial excitement centered around high response rates in clinical trials of idelalisib, its therapeutic success has been hindered by the incidence of severe opportunistic infections. To examine the potential contribution of idelalisib to the increased risk of infection, we investigated the effects of idelalisib on the immune cell compartments of healthy donors (HDs) and CLL patients. PI3K∂ blockade by idelalisib reduced the expression levels of inhibitory checkpoint molecules in T cells isolated from both HDs and CLL patients. In addition, the presence of idelalisib in cultures significantly decreased T-cell-mediated cytotoxicity and granzyme B secretion, as well as cytokine secretion levels in both cohorts. Furthermore, idelalisib reduced the proliferation and cytotoxicity of HD NK cells. Collectively, our data demonstrate that both human T and NK cells are highly sensitive to PI3K∂ inhibition. Idelalisib interfered with the functions of T and NK cell cells from both HDs and CLL patients. Therefore, idelalisib might contribute to an increased risk of infections regardless of the underlying B-cell malignancy.


Leukemia ◽  
2008 ◽  
Vol 22 (11) ◽  
pp. 2123-2127 ◽  
Author(s):  
E Chapiro ◽  
◽  
I Radford-Weiss ◽  
C Bastard ◽  
I Luquet ◽  
...  

2015 ◽  
Vol 90 ◽  
pp. S25-S28 ◽  
Author(s):  
Timothy M. Cox ◽  
Barry E. Rosenbloom ◽  
Roger A. Barker

2014 ◽  
Vol 235 (1) ◽  
pp. 113-124 ◽  
Author(s):  
Elena V Pavlova ◽  
Joy Archer ◽  
Susan Z Wang ◽  
Nick Dekker ◽  
Johannes MFG Aerts ◽  
...  

Author(s):  
Miranda H. Meeuwsen ◽  
Anne K. Wouters ◽  
Lorenz Jahn ◽  
Renate S. Hagedoorn ◽  
Michel G.D. Kester ◽  
...  

2008 ◽  
Vol 36 (10) ◽  
pp. 1429-1440
Author(s):  
Shigeo Mori ◽  
Shizuo Hagiwara ◽  
Hideki Kodo ◽  
Noboru Mohri

Sign in / Sign up

Export Citation Format

Share Document